0001169987-19-000001.txt : 20190514
0001169987-19-000001.hdr.sgml : 20190514
20190513183133
ACCESSION NUMBER: 0001169987-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190514
DATE AS OF CHANGE: 20190513
EFFECTIVENESS DATE: 20190514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-339495
FILM NUMBER: 19819968
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0708
D
LIVE
0001505512
Regulus Therapeutics Inc.
10628 SCIENCE CENTER DRIVE
SUITE 100
SAN DIEGO
CA
CALIFORNIA
92121
858-202-6300
DELAWARE
None
None
Corporation
true
Joseph
P.
Hagan
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Daniel
R.
Chevallard
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Executive Officer
Christopher
Aker
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Executive Officer
David
Baltimore
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Director
Stelios
Papadopoulos
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Director
William
H.
Rastetter
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Director
Pascale
Witz
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Director
Hugh
Rosen
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Director
Kathryn
L.
Collier
c/o Regulus Therapeutics Inc.
10628 Science Center Dr., Suite 100
San Diego
CA
CALIFORNIA
92121
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2019-05-07
false
true
true
true
false
0
H.C. Wainwright Co.
375
None
None
430 Park Avenue, 4th Floor
New York
NY
NEW YORK
10022
CA
CALIFORNIA
CT
CONNECTICUT
MD
MARYLAND
MA
MASSACHUSETTS
NY
NEW YORK
false
79343959
16736889
62607070
"Total Offering Amount" includes amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's Common Stock (assuming no cashless exercise).
false
21
2301322
0
"Sales Commissions" includes amounts payable by the Issuer for both the initial closing and the milestone closing.
0
false
Regulus Therapeutics Inc.
/s/ Christopher Aker
Christopher Aker
Sr. VP and General Counsel
2019-05-13